about
Visceral adiposity index is associated with insulin sensitivity and adipocytokine levels in newly diagnosed acromegalic patients.The metabolic profile in active acromegaly is gender-specific.OCT is not useful for detection of minimal diabetic retinopathy in type 1 diabetes.Correlation between severity of growth hormone deficiency and thyroid metabolism and effects of long-term growth hormone treatment on thyroid function in children with idiopathic growth hormone deficiency.Janus kinase (JAK) 2 V617F mutation as the cause of primary thrombocythemia in acromegaly with severe visceromegaly and divergence between growth hormone and insulin-like growth factor-1 concentrations during the follow-up: causal or casual associatPredictors of microvascular complications in type 1 diabetic patients at onset: the role of metabolic memory.High prevalence of hypovitaminosis D in Sicilian children affected by growth hormone deficiency and its improvement after 12 months of replacement treatment.Comparison between euglycemic hyperinsulinemic clamp and surrogate indices of insulin sensitivity in children with growth hormone deficiency.One-hour post-load plasma glucose level is associated with a worse metabolic profile in children with GH deficiency.Efficacy of combined treatment with pasireotide, pegvisomant and cabergoline in an acromegalic patient resistant to other treatments: a case report.Reduction in insulin sensitivity and inadequate β-cell capacity to counteract the increase in insulin resistance in children with idiopathic growth hormone deficiency during 12 months of growth hormone treatment.Early lung function abnormalities in acromegaly.No phenotypic differences for polycystic ovary syndrome (PCOS) between women with and without type 1 diabetes mellitus.Alteration of the growth hormone axis, visceral fat dysfunction, and early cardiometabolic risk in adults: the role of the visceral adiposity indexCorneal thickness in children with growth hormone deficiency: The effect of GH treatmentMetabolic parameters and adipokine profile during GH replacement therapy in children with GH deficiencyRelative Hypoleptinemia in Poorly Controlled Patients with Type 1 DiabetesGlycometabolic control in acromegalic patients with diabetes: a study of the effects of different treatments for growth hormone excess and for hyperglycemiaGrowth hormone and hematopoiesis: A retrospective analysis on a large cohort of children with growth hormone deficiency
P50
Q42507682-81A13468-C75D-47B4-B7EC-FF3643261564Q42516233-3CABD6FD-D645-411D-8984-87BB19A0C21CQ43068385-468E5670-5447-4ED9-8150-453F5A0508A2Q43714810-66358BA8-C918-4608-8A19-30B37AF2632FQ43990138-E44F0C35-9614-426D-A64B-BD1A0960C710Q44970575-694F02CE-7717-4297-A1B1-5592D7BBA2D6Q46137780-7FFFCB87-B0F3-462A-BB56-91493F2B5432Q47253938-7E4211E9-E4E4-4688-9CFF-1C5754793457Q48105081-55359C3A-BDC5-4277-B11A-D17B27189BE4Q48181953-551B2F06-B7BD-4B90-96DF-CB3926C92DFDQ51314968-A7FD5A5B-280B-4F46-8928-F76F00F74995Q51651242-04FAB2F5-4CBA-470A-B5BC-2083BE97A100Q54586058-8152BCBC-76F7-49B1-B9B7-A2A52328839EQ60690810-DE4C07CC-14AA-4435-BB54-1E9ACAAEF191Q63256599-9E02BAB0-2932-4E11-8045-A6B18B596B56Q63256714-33A0849A-5ED3-4C11-881D-6264D2ECE23FQ63256731-8E3D4194-AA43-4B89-92DB-F4CD5C2C3EB1Q84006869-21C11332-2D9D-4F45-AAA1-826BC4A24E5BQ90575236-6C13A425-443D-4752-B1E6-03417ED0A0A0
P50
description
Forscher
@de
chercheur
@fr
investigador
@es
researcher
@en
հետազոտող
@hy
研究者
@zh
name
Alessandro Ciresi
@ast
Alessandro Ciresi
@en
Alessandro Ciresi
@es
Alessandro Ciresi
@nl
type
label
Alessandro Ciresi
@ast
Alessandro Ciresi
@en
Alessandro Ciresi
@es
Alessandro Ciresi
@nl
prefLabel
Alessandro Ciresi
@ast
Alessandro Ciresi
@en
Alessandro Ciresi
@es
Alessandro Ciresi
@nl
P1153
16201784700
P21
P31
P496
0000-0002-7383-7712